glp-1 dementia news GLP-1R agonists protect against Alzheimer's disease by rewiring energy regulation GLP-1 drugs linked to lower
Description
Learn why it happens, how common it is, and when to talk to your doctor.
Here's what researchers found.
What the EVOKE and EVOKE+ trials found At the 18th Clinical Trials on Alzheimers Disease (CTAD) conference (Dec
Methods We conducted a systematic review of studies from PubMed, Embase, and Cochrane databases (until November 2024), as well as relevant abstracts from Digestive Disease Week (DDW) 2024 and American College of Gastroenterology (ACG) 2024 to assess the impact of GLP-1 receptor agonists (GLP-1 RAs) on EGD
Promotes Beneficial Bacteria & Short-Chain Fatty Acids*
